Amide Lab at the Engine Accelerator in Cambridge, MA (courtesy Amide)
MIT spinout aims to improve manufacturing of peptides
Amide Technologies is now marketing its peptide manufacturing technology at a time when peptide-based therapies such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro are …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
